HEADER TRANSFERASE 26-JUL-19 6SDD TITLE CRYSTAL STRUCTURE OF D1228V CMET BOUND BY BMS-777607 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.W.COLLIE,C.PHILLIPS REVDAT 2 02-OCT-19 6SDD 1 JRNL REVDAT 1 14-AUG-19 6SDD 0 JRNL AUTH G.W.COLLIE,C.M.KOH,D.J.O'NEILL,C.J.STUBBS,P.KHURANA, JRNL AUTH 2 A.EDDERSHAW,A.SNIJDER,F.MAURITZSON,L.BARLIND,I.L.DALE, JRNL AUTH 3 J.SHAW,C.PHILLIPS,E.J.HENNESSY,T.CHEUNG,A.J.NARVAEZ JRNL TITL STRUCTURAL AND MOLECULAR INSIGHT INTO RESISTANCE MECHANISMS JRNL TITL 2 OF FIRST GENERATION CMET INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 10 1322 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31531204 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00276 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 27096 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 1305 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2764 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2720 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2630 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE : 0.2770 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.85 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 134 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2129 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.97480 REMARK 3 B22 (A**2) : -1.46110 REMARK 3 B33 (A**2) : -11.51370 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.152 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.132 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.146 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.130 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2227 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3022 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 738 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 38 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 322 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2227 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 280 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2383 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.94 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.65 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.58 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6SDD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-19. REMARK 100 THE DEPOSITION ID IS D_1292103521. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92819 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27276 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 54.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8 % ETHANOL, 20 % PEG8K, 0.1 M PCPT PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.97800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.02350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.90700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.02350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.97800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.90700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1059 REMARK 465 PRO A 1060 REMARK 465 GLU A 1061 REMARK 465 ARG A 1086 REMARK 465 GLY A 1087 REMARK 465 ARG A 1114 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 GLY A 1119 REMARK 465 GLU A 1120 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 ILE A 1345 REMARK 465 GLY A 1346 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CD OE1 NE2 REMARK 470 ASN A1081 CG OD1 ND2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 GLN A1123 CG CD OE1 NE2 REMARK 470 LYS A1199 CE NZ REMARK 470 LYS A1215 CE NZ REMARK 470 ARG A1227 CD NE CZ NH1 NH2 REMARK 470 LYS A1240 CG CD CE NZ REMARK 470 LYS A1259 CG CD CE NZ REMARK 470 GLU A1306 CG CD OE1 OE2 REMARK 470 LYS A1318 CD CE NZ REMARK 470 LYS A1323 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A1082 76.86 -118.65 REMARK 500 ARG A1203 -17.29 79.90 REMARK 500 ASP A1231 35.11 -95.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 353 A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1402 DBREF 6SDD A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 6SDD VAL A 1228 UNP P08581 ASP 1228 ENGINEERED MUTATION SEQRES 1 A 309 GLY ASP SER ASP ILE SER SER PRO LEU LEU GLN ASN THR SEQRES 2 A 309 VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 3 A 309 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 4 A 309 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 5 A 309 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 6 A 309 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 7 A 309 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 8 A 309 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 9 A 309 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 10 A 309 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 11 A 309 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 12 A 309 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 13 A 309 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 15 A 309 VAL ALA ASP PHE GLY LEU ALA ARG VAL MET TYR ASP LYS SEQRES 16 A 309 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 17 A 309 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 18 A 309 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 19 A 309 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 20 A 309 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 21 A 309 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 22 A 309 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 23 A 309 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 24 A 309 ILE SER ALA ILE PHE SER THR PHE ILE GLY HET 353 A1401 36 HET GOL A1402 6 HETNAM 353 N-{4-[(2-AMINO-3-CHLOROPYRIDIN-4-YL)OXY]-3- HETNAM 2 353 FLUOROPHENYL}-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-1,2- HETNAM 3 353 DIHYDROPYRIDINE-3-CARBOXAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 353 C25 H19 CL F2 N4 O4 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *154(H2 O) HELIX 1 AA1 LEU A 1062 GLN A 1067 1 6 HELIX 2 AA2 GLY A 1072 SER A 1074 5 3 HELIX 3 AA3 SER A 1122 ASP A 1133 1 12 HELIX 4 AA4 ASP A 1164 ASN A 1171 1 8 HELIX 5 AA5 THR A 1177 LYS A 1198 1 22 HELIX 6 AA6 ALA A 1206 ARG A 1208 5 3 HELIX 7 AA7 PRO A 1246 MET A 1250 5 5 HELIX 8 AA8 ALA A 1251 GLN A 1258 1 8 HELIX 9 AA9 THR A 1261 THR A 1278 1 18 HELIX 10 AB1 ASN A 1288 PHE A 1290 5 3 HELIX 11 AB2 ASP A 1291 GLN A 1298 1 8 HELIX 12 AB3 PRO A 1309 TRP A 1320 1 12 HELIX 13 AB4 LYS A 1323 ARG A 1327 5 5 HELIX 14 AB5 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 6 VAL A1070 ILE A1071 0 SHEET 2 AA1 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 AA1 6 LEU A1154 PRO A1158 -1 O VAL A1156 N GLY A1144 SHEET 4 AA1 6 ILE A1105 SER A1111 -1 N ALA A1108 O LEU A1157 SHEET 5 AA1 6 VAL A1092 LEU A1097 -1 N LEU A1097 O ILE A1105 SHEET 6 AA1 6 LEU A1076 VAL A1083 -1 N ILE A1077 O THR A1096 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 2 SER A1236 VAL A1237 0 SHEET 2 AA3 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 14 ILE A1084 ALA A1108 LYS A1110 MET A1131 SITE 2 AC1 14 LEU A1140 LEU A1157 PRO A1158 MET A1160 SITE 3 AC1 14 LEU A1195 MET A1211 VAL A1220 ALA A1221 SITE 4 AC1 14 ASP A1222 PHE A1223 SITE 1 AC2 2 LYS A1190 HOH A1531 CRYST1 57.956 67.814 90.047 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017254 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014746 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011105 0.00000